Caffeine Studies Cycle Every Fifteen Years, Repackaged as Discovery

A new study claims caffeine timing is personal, not universal — but this exact finding keeps cycling back into prominence every fifteen years, each time repackaged as fresh discovery.

The pattern started in the 1980s with urine-marker studies that found measurable differences between fast and slow caffeine metabolizers. By the late 1990s, labs switched to genetic sequencing and read CYP1A2 status directly from blood. The biology didn't change — only the measurement technology did.

The same underlying variation was suddenly reframed. It was no longer measurement noise or expected individual difference, but "personalization." In 2015 and onward, as direct-to-consumer genetic testing kits entered the market, research funding for caffeine-metabolism studies shifted visibly toward companies with commercial skin in the game.

Companies needed a story that justified genetic testing to consumers. "One size fits all is wrong, your biology is unique" sells a test. A universal protocol doesn't. The buried implication is that funding source shapes what a finding means before the finding is even made. The same biological data, human metabolic variation. Read as either a universal rule or an individual signature depending entirely on what the funding landscape permits researchers to publish.

The pattern suggests less about coffee and more about how science narratives align with market demand. When you're evaluating claims about personalization in any domain from fitness, education, and mental health, ask this question. Who benefits if the answer is "it depends on you" rather than "here's what works"? The framing itself is the product.